This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by GEDDES, J.
Right arrow Articles by GOODWIN, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GEDDES, J.
Right arrow Articles by GOODWIN, G.
The British Journal of Psychiatry (2001) 178: s191-s194
© 2001 The Royal College of Psychiatrists

Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials

JOHN GEDDES, MRCPsych

GUY GOODWIN, FRCPsych

Department of Psychiatry, University of Oxford, UK

Correspondence: Dr John Geddes, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK. Tel: +44 (0) 1865 226480; fax: +44 (0) 1865 793101; e-mail: john.geddes{at}psych.ox.ac.uk

Declaration of interest None.

Background The increasing use of the methods of evidence-based medicine to keep up-to-date with the research literature highlights the absence of high-quality evidence in many areas in psychiatry.

Aims To outline current uncertainties in the maintenance treatment of bipolar disorder and to describe some of the decisions involved in designing a large simple trial.

Method We describe some of the strategies of evidence-based medicine, and how they can be applied in practice, focusing specifically on the area of bipolar disorder.

Results One of the key clinical uncertainties in the treatment of bipolar disorder is the place of maintenance drug treatments and their relative efficacy. A large-scale study, the Bipolar Affective Disorder: Lithium Anticonvulsant Evaluation (BALANCE) trial, is proposed to compare the effectiveness of lithium, valproate and the combination of lithium and valproate.

Conclusions Providing reliable answers to key clinical questions in psychiatry will require new approaches to clinical trials. These will need to be far larger than previously appreciated and will therefore need to be collaborative ventures involving front-line clinicians.